Could the combination of immunotherapy and target therapy be a potential double edge sword for glioblastoma treatment? A correspondence

Affiliations

• ¹ Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Cambridge, USA.
• ² Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Cambridge, USA. [email protected].
• ³ Harvard T.H Chan School of Public Health, Harvard University, Cambridge, USA. [email protected].
• ⁴ Harvard T.H Chan School of Public Health, Harvard University, Cambridge, USA.